BioCentury | Aug 18, 2014
Clinical News
Tirosint levothyroxine: Postmarketing study started
...Akrimax Pharmaceuticals LLC (Cranford, N.J.) began the open-label, U.S. postmarketing CONTROL trial to evaluate once-daily Tirosint...
...said Tirosint is the only levothyroxine therapy in a liquid gel cap. Institute Biochimique manufactures Tirosint...
...Akrimax, which distributes the product in the U.S. Institut Biochimique S.A. , Lugano, Switzerland Product: Tirosint...
...said Tirosint is the only levothyroxine therapy in a liquid gel cap. Institute Biochimique manufactures Tirosint...
...Akrimax, which distributes the product in the U.S. Institut Biochimique S.A. , Lugano, Switzerland Product: Tirosint...